BioWorld

Sep. 2, 2004

View Archived Issues

MGI's 'Great Day': Deal To Market Dacogen, Two Companies Bought

MGI Pharma Inc.'s stock surged nearly 20 percent Wednesday after it announced a marketing deal for SuperGen Inc.'s Dacogen, as well as its plans to acquire two private companies focused on oncology. (BioWorld Today) Read More

Forest's Second Alzheimer's Drug Fails In Early Phase III

Read More

Gothenburg Biotech Research Focuses On Tools, Stem Cells

Read More

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Read More

Other News To Note

Read More